Dr. Thomas Colletti, DHSc, PA-C
For decades, clomiphene citrate (CC) has been the first-line treatment in anovulatory infertile women1. Recent studies have investigated the use of letrozole, an aromatase inhibitor (AI), to induce ovulation in anovulatory women who have polycystic ovarian syndrome (PCOS). The aim is to compare the effectiveness of letrozole in inducing ovulation as compared to clomiphene citrate.
De la Cruz Novelo, Naomie
"AI's: The Future of Ovulation Induction,"
Lynchburg Journal of Medical Science: Vol. 1
, Article 62.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol1/iss3/62
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.